Skip to content
NeuroDerm
Continuous Therapy
NeuroDerm
  • Home
  • NeuroDerm
    • About NeuroDerm
    • Management
    • Board
    • Scientific Advisory Board
  • Parkinson’s Disease
    • PD Overview
    • Resources
  • Pipeline Products
    • Overview
    • ND0612
    • ND0701 for severe PD
    • Scientific Publications
  • Clinical trials
    • What is ND0612 ?
    • ND0612 ongoing clinical trials
  • Careers
  • Contact
  • Home
  • NeuroDerm
    • About NeuroDerm
    • Management
    • Board
    • Scientific Advisory Board
  • Parkinson’s Disease
    • PD Overview
    • Resources
  • Pipeline Products
    • Overview
    • ND0612
    • ND0701 for severe PD
    • Scientific Publications
  • Clinical trials
    • What is ND0612 ?
    • ND0612 ongoing clinical trials
  • Careers
  • Contact

Tag Archives: 2012

You are here:
  1. Home
  2. Entries tagged with "2012"

NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson’s Disease

Press ReleasesBy Foothold SystemsJune 18, 2012

“This first trial of ND0612 in man is a significant step in the development of a new levodopa treatment standard for Parkinson’s disease” said Oded S. Lieberman, PhD, NeuroDerm’s Chairman and CEO.

NeuroDerm
Copyright NeuroDerm © 2014 All rights reserved.         Privacy Policy  |  Cookie Policy
Go to Top
Information about cookies and their deactivation you can find in our Privacy Policy. By using our website, you agree to the use of cookiesok, I agree